טוען...
Glycogen Synthase Kinase-3 Inhibitors as Potent Therapeutic Agents for the Treatment of Parkinson Disease.
[Image: see text] Parkinson's disease (PD) is a devastating neurodegenerative disorder characterized by degeneration of the nigrostriatal dopaminergic pathway. Because the current therapies only lead to temporary, limited improvement and have severe side effects, new approaches to treat PD need...
שמור ב:
| Main Authors: | , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Chemical
Society
2012
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3582296/ https://ncbi.nlm.nih.gov/pubmed/23421686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cn300182g |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|